Open access
Sep 2026
Single-cell RNA profiling suggests goflikicept-mediated immune modulation in idiopathic recurrent pericarditis
Goflikicept effectively normalized dysregulated immune responses in IRP, supporting the broader therapeutic potential of IL-1 blockade in NLRP3-mediated inflammatory diseases.
A. Golovkin, E. Markelova, E. Ignatieva et al.
· Inflammation Research · 0 citations